Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide

被引：11
|
作者：
Saviola, A [1 ]
Luppi, M [1 ]
Potenza, L [1 ]
Morselli, M [1 ]
Ferrari, A [1 ]
Riva, G [1 ]
Torelli, G [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Sect Haematol, Dept Haematol & Oncol, I-4100 Modena, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2003年 / 123卷 / 04期
关键词：
veno-occlusive disease; leukaemia; gemtuzumab ozogamicin; defibrotide; Mylotarg;
D O I：
10.1046/j.1365-2141.2003.04667.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752 / 753
页数：2
相关论文
共 50 条
  • [21] Defibrotide for the treatment of veno-occlusive disease in children.
    Corbacioglu, S
    Greil, J
    Laws, HJ
    Dilloo, D
    Strahm, B
    Peters, C
    Gross-Wieltsch, U
    Sykora, KW
    Ridolfi-Leuthy, A
    Basu, O
    Gruhn, B
    Friedrich, W
    Guengoer, T
    Mihatsch, W
    Schulz, A
    BLOOD, 2002, 100 (11) : 111A - 111A
  • [22] Use of defibrotide in the treatment and prevention of veno-occlusive disease
    Richardson, Paul
    Linden, Erica
    Revta, Carolyn
    Ho, Vincent
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (04) : 365 - 376
  • [23] Defibrotide as salvage therapy for hepatic veno-occlusive disease (VOD).
    Abecasis, M
    Ferreira, I
    Guimaraes, A
    Machado, A
    BONE MARROW TRANSPLANTATION, 1999, 23 : S222 - S222
  • [24] Successful Treatment with Danhong Injection for Hepatic Veno-occlusive Disease
    Yao Jia-Yin
    Zhi Min
    Cao Wu-Teng
    Huang Yan
    Li Chu-Jun
    HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 992 - 995
  • [25] Defibrotide for the treatment of veno-occlusive disease:: the paediatric experience
    Corbacioglu, S
    Greil, J
    Laws, H
    Dilloo, D
    Strahm, B
    Peters, C
    Sykora, K
    Luethy, AR
    Friedrich, W
    Güngör, T
    Schulz, A
    BONE MARROW TRANSPLANTATION, 2002, 30 : S11 - S12
  • [26] Treatment of severe veno-occlusive disease with defibrotide (DF)
    Madar, Olivier
    Salmon, Maxime
    Mounier, Nicolas
    Desrayaud-Jourdan, Nathalie
    Madelaine-Chambrin, Isabelle
    Faure, Pierre
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 505 - 505
  • [27] Gemtuzumab ozogamicin (Mylotarg™) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease
    Nabhan, C
    Rundhaugen, L
    Jatoi, M
    Riley, MB
    Boehlke, L
    Peterson, LC
    Tallman, MS
    ANNALS OF ONCOLOGY, 2004, 15 (08) : 1231 - 1236
  • [28] Recent developments with defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome
    Duncan, Christine
    Kahn, Justine
    Grupp, Stephan A.
    Richardson, Paul G.
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (7-8): : 337 - 347
  • [29] The treatment of late-onset hepatic veno-occlusive disease following haematopoietic stem cell transplantation using defibrotide: a case study
    Waller, M.
    Tholouli, E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 293 - 293
  • [30] Defibrotide for the treatment of veno-occlusive disease after liver transplantation
    Mor, E
    Pappo, O
    Bar-Nathan, N
    Shaharabani, E
    Shapira, Z
    Tur-Kaspa, R
    Ben-Ari, Z
    TRANSPLANTATION, 2001, 72 (07) : 1237 - 1240
12345